Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease por Walter Suárez Carmona | Feb 3, 2025
The LDL cumulative exposure hypothesis: evidence and practical applications por Walter Suárez Carmona | Feb 3, 2025
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies por Walter Suárez Carmona | Feb 3, 2025
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease? por Walter Suárez Carmona | Feb 3, 2025
